OTC:MGROF MustGrow Biologics (MGROF) Stock Price, News & Analysis → If you have $2,500 bucks… check this out (From DTI) (Ad) Free MGROF Stock Alerts C$0.74 -0.05 (-6.33%) (As of 04/26/2024 ET) Add Compare Share Share Today's RangeC$0.73▼C$0.8150-Day RangeC$0.74▼C$1.0452-Week RangeC$0.57▼C$1.81Volume212,536 shsAverage Volume6,820 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get MustGrow Biologics alerts: Email Address Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About MustGrow Biologics Stock (OTC:MGROF)MustGrow Biologics Corp., an agricultural biotech company, focuses on development and commercialization of natural biopesticides, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops; and TerraMG, a mustard-derived soil biopesticide technology for use as a preplant soil biopesticide for soil-borne diseases and pests for various crops, such as fruits & vegetables, bananas, canola, and pulses. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.Read More MGROF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MGROF Stock News HeadlinesApril 25, 2024 | finance.yahoo.comMustGrow Biologics Full Year 2023 Earnings: CA$0.014 loss per share (vs CA$0.11 loss in FY 2022)April 25, 2024 | americanbankingnews.comMustGrow Biologics (OTC:MGROF) Shares Down 5.1% April 28, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 9, 2024 | finance.yahoo.comMustGrow Biologics Corp. (MGROF)February 6, 2024 | finance.yahoo.comMustGrow Receives Registration Approval for TerraSante(TM) in Oregon StateDecember 13, 2023 | finance.yahoo.comMustGrow Provides Additional Information and Clarification on Commercial License Agreement with BayerDecember 11, 2023 | finance.yahoo.comMustGrow Biologics agrees to commercial licence agreement with Bayer covering Europe, Middle East and AfricaNovember 15, 2023 | finance.yahoo.comMustGrow Biologics announces company has received approval for TerraSante in Washington StateApril 28, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.November 9, 2023 | finance.yahoo.comMustGrow to Present at the Harbor Access Global SMID Cap Investor Conference November 16thNovember 7, 2023 | msn.comMustGrow to commence large-scale field trials via NexusBioAg BAT programNovember 7, 2023 | finance.yahoo.comMustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT ProgramOctober 31, 2023 | finance.yahoo.comMustGrow Biologics announces Terrasante fertilizer granted USDA organic approvalOctober 31, 2023 | morningstar.comAbCellera Biologics Inc Ordinary Shares ABCLOctober 31, 2023 | finance.yahoo.comMustGrow Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment TechnologyOctober 19, 2023 | finance.yahoo.comMustGrow Announces Participation at Biocontrol Industry Conference and Investor WebinarSeptember 12, 2023 | finance.yahoo.comMustGrow Announces Investor Relations Agreement with Harbor AccessSeptember 6, 2023 | finance.yahoo.comMustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project ExpansionJune 29, 2023 | finance.yahoo.comMustGrow Biologics Corp. Announces Results of Shareholder MeetingJune 13, 2023 | finance.yahoo.comMustGrow Completes Initial Commercial Production Run via Contract ManufacturerJune 6, 2023 | proactiveinvestors.comMustGrow Biologics: Revolutionizing agriculture with natural biologic solutionsJune 6, 2023 | markets.businessinsider.comNoble Financial Keeps Their Hold Rating on MustGrow Biologics (MGROF)June 5, 2023 | proactiveinvestors.comMustGrow Biologics inks deal with Bio Ag Product Strategies for soil amendment and biofertility technologiesMay 23, 2023 | proactiveinvestors.comMustGrow Biologics extends partnership deal with Janssen PMP for mustard plant-based technologiesMay 23, 2023 | finance.yahoo.comMustGrow and Janssen PMP, a Division of Janssen Pharmaceutica NV, Extend Exclusive Global PartnershipApril 24, 2023 | finance.yahoo.comMustGrow Investor Webcast: Wednesday, April 26th at 4:00pm ETApril 19, 2023 | proactiveinvestors.comMustGrow Biologics' expansion into additional markets highlighted by analystsSee More Headlines Receive MGROF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MustGrow Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTC SectorBasic Materials Industry Agricultural Inputs Sub-IndustryN/A Current SymbolOTC:MGROF CUSIPN/A CIKN/A Webwww.mustgrow.ca Phone306-668-2652FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Corey J. Giasson B.Sc. (Age 46)MBA, President, CEO & Director Comp: $212.04kMr. Todd L. Lahti CA (Age 58)CFA, CFO & Corporate Secretary Comp: $194.37kMr. Colin BletskyCOO & DirectorKey CompetitorsDanakaliOTCMKTS:SBMSFItafosOTCMKTS:MBCFJG BoswellOTCMKTS:BWELK+S AktiengesellschaftOTCMKTS:KPLUYK+S AktiengesellschaftOTCMKTS:KPLUFView All Competitors MGROF Stock Analysis - Frequently Asked Questions How have MGROF shares performed in 2024? MustGrow Biologics' stock was trading at C$0.97 at the beginning of the year. Since then, MGROF shares have decreased by 23.7% and is now trading at C$0.74. View the best growth stocks for 2024 here. How do I buy shares of MustGrow Biologics? Shares of MGROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:MGROF) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MustGrow Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.